B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
https://annals.org/aim/article-abstract/2729813/b-lymphocyte-depletion-patients-myalgic-encephalomyelitis-chronic-fatigue-syndrome-randomized...
Rituximab Serum Concentrations and Anti- Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome
Rekeland, Fluge, Mella et al
(only the abstract is available for now)
Findings
There were no significant differences in mean serum rituximab...
Research Conference in Oslo 20 - 21. November 2017
The Norwegian ME Association is preparing a research conference in cooperation with Oslo university Hospital and the Norwegian Institute of public Health. The first day is for researchers only, primarily from Scandinavia. The second day has an...
Rituximab (RituxME)
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
Øystein Fluge and Olav Mella
BMC Neurology
2009
Link to article
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.